Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results. (Q40445678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Maria Giovanna Marrosu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Maria Trojano

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

P Gallo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

A Ghezzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

M Capobianco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

V Martinelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

C Milanese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

L Moiola

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

N Milani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

L La Mantia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

F Patti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

C Pozzilli

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

G Comi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Zaffaroni

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Immunomodulatory Treatment of Early-onset MS (ITEMS) Group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

30 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Neurological Sciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

127-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0804-2

Course and prognosis in early-onset MS: comparison with adult-onset forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0804-2

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0804-2

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-007-0804-2

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a

1 reference

12 December 2020

Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis

1 reference

12 December 2020

The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver

1 reference

12 December 2020

Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis

1 reference

12 December 2020

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study

1 reference

12 December 2020

Multiple sclerosis in childhood and adolescence: clinical features and management

1 reference

12 December 2020

Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study

1 reference

12 December 2020

Prospective study of multiple sclerosis with early onset

1 reference

12 December 2020

Early onset multiple sclerosis: a longitudinal study.

1 reference

12 December 2020

Interferons in relapsing remitting multiple sclerosis: a systematic review

1 reference

12 December 2020

10.1007/S10072-007-0804-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603763%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference